Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
4 clinical trials · Sponsor
◉ Watch Chase Pharmaceuticals Corporation, an affiliate of Allergan plc
| Record | Firm | Date |
|---|---|---|
| CPC-201 Alzheimer's Disease Type Dementia: PET Study (NCT02860065) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2016-09-30 |
| A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type (NCT02549196) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2015-10-07 |
| Long Term Extension Safety Study in Patients With Dementia of the Alzheimer's Type Who Completed Study CPC-001-07 (NCT02434666) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2015-01-08 |
| A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia (NCT02185053) | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 2014-07-31 |
Track Chase Pharmaceuticals Corporation, an affiliate of Allergan plc automatically
Every clearance here is in the API, with alerts when new ones post.